FDA Adverse Event Malfunction Summary report: N

BINAX NOW COVID-19 HOME TEST

MDR report key: 12282146 · Received August 5, 2021

Report

Report Number
1221359-2021-02218
Event Type
Malfunction
Date Received
August 5, 2021
Date of Event
July 14, 2021
Report Date
November 29, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

H10: TESTING WAS PERFORMED ON RETAIN KIT LOT 153476 WITH THE ABBOTT DIAGNOSTICS SCARBOROUGH'S LIMIT OF DETECTION (LOD) POSITIVE QUALITY CONTROL X3 DEVICES AND NEGATIVE (BLANK) SWABS X3 DEVICES. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING AND QUALITY CONTROL RELEASE TESTING WERE REVIEWED FOR KIT PART NUMBER 195-160 / LOT 153476 AND DEVICE PART NUMBER 195-430H / LOT 148405 AND THEY MET RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 153476 SHOWED THAT THE COMPLAINT RATE IS (B)(4). A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 153476 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH, INC. WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE, HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE.

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.

Description of Event or Problem · 1

THE CUSTOMER REPORTED CONFLICTING RESULT WITH THE BINAX NOW COVID-19 ANTIGEN SELF TEST. THE CUSTOMER STATED THAT HERE IS A DARK PINK LINE IN THE CONTROL AND WHEN HE PRESSED THE TEST CARD THERE IS A PINK FAINT LINE IN THE SAMPLE. THE CUSTOMER CONFIRMED THAT HE NO LONGER SEE THE PINK FAINT LINE IN THE SAMPLE AFTER HE NO LONGER PRESSED THE TEST CARD. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1181778 BINAX NOW COVID-19 HOME TEST LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 153476 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 Unknown